These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1364175)

  • 1. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents.
    Speeg KV; Patwardhan RV; Avant GR; Mitchell MC; Schenker S
    Gastroenterology; 1982 Jan; 82(1):89-96. PubMed ID: 6118315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists.
    Reilly PE; Mason SR; Gillam EM
    Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A; Savenije-Chapel EM; Kroes BH
    Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of H2-receptor- and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism.
    Scheuch E; Walter R; Hadasová E; Amon I; Siegmund W
    Pharmazie; 1996 Jul; 51(7):493-7. PubMed ID: 8774841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T; Levine M; Bandiera SM; Bellward GD
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of H2-receptor antagonists on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity.
    Svensson CK; Tomilo M
    Drug Metab Dispos; 1992; 20(1):74-8. PubMed ID: 1371435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of microsomal enzyme activity of the liver by various H2 receptor antagonists].
    Jensen JC; Gugler R
    Z Gastroenterol; 1987 Feb; 25(2):112-8. PubMed ID: 2882636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
    Pasanen M; Arvela P; Pelkonen O; Sotaniemi E; Klotz U
    Biochem Pharmacol; 1986 Dec; 35(24):4457-61. PubMed ID: 2878667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450.
    Wright AW; Winzor DJ; Reilly PE
    Xenobiotica; 1991 Feb; 21(2):193-203. PubMed ID: 2058175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.
    Chang T; Levine M; Bellward GD
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1450-5. PubMed ID: 1545404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famotidine: a notable lack of drug interactions.
    Humphries TJ
    Scand J Gastroenterol Suppl; 1987; 134():55-60. PubMed ID: 2889260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of famotidine with rat liver microsomes, a study showing less inhibition of drug metabolism than with cimetidine.
    Imai Y; Inada M; Tamura S; Noda S; Kawata S; Minami Y; Tarui S
    Pharmacol Res Commun; 1986 Jul; 18(7):629-38. PubMed ID: 2876442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.
    Orishiki M; Matsuo Y; Nishioka M; Ichikawa Y
    Int J Biochem; 1994 Jun; 26(6):751-8. PubMed ID: 8063004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of H2-receptor antagonists, cimetidine and ranitidine with microsomal drug metabolizing and other systems in liver.
    Gill M; Sanyal SN; Sareen ML
    Indian J Exp Biol; 1991 Sep; 29(9):852-6. PubMed ID: 1794870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.